FWP
ABBV icon

Fiduciary Wealth Partners’s AbbVie ABBV Stock Holding History

Fiduciary Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$291K Buy
1,158
+26
+2% +$5.59K 0.16% 51
2026
Q1 		$246K Sell
1,132
-1,008
-47% -$224K 0.16% 50
2025
Q4 		$489K Sell
2,140
-28
-1% -$6.38K 0.2% 42
2025
Q3 		$502K Buy
2,168
+510
+31% +$104K 0.21% 42
2025
Q2 		$308K Buy
1,658
+503
+44% +$93.5K 0.29% 39
2025
Q1 		$242K Buy
+1,155
New +$225K 0.21% 32

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fiduciary Wealth Partners's ABBV Position: Q2 2026 in Review

Fiduciary Wealth Partners increased its AbbVie (ABBV) stake by 2.3% in Q2 2026, buying an estimated $5.59K and bringing the position to 1,158 shares worth $291K. The position accounts for 0.16% of the portfolio, ranked #51.

Fiduciary Wealth Partners first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. The position peaked at $502K in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fiduciary Wealth Partners held 1,158 shares of AbbVie worth $291K as of Q2 2026.
  • Fiduciary Wealth Partners bought 26 AbbVie shares in Q2 2026, an estimated $5.59K.
  • AbbVie made up 0.16% of Fiduciary Wealth Partners's portfolio in Q2 2026, its #51 holding.
  • Fiduciary Wealth Partners first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • Fiduciary Wealth Partners's AbbVie position peaked at $502K in Q3 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fiduciary Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.